Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-08-26), the Forward Annual Dividend Yield of Huadong Medicine Co is 3.42%.
As of today (2026-08-26), the Trailing Annual Dividend Yield of Huadong Medicine Co is 3.42%.
SZSE:000963's Forward Dividend Yield % is ranked better than 72.87% of 505
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs SZSE:000963: 3.42
During the past 3 years, the average Dividends Per Share Growth Rate was 47.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 33.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 6.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Huadong Medicine Co was 60.80% per year. The lowest was -28.00% per year. And the median was 16.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Huadong Medicine Co (SZSE:000963) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Huadong Medicine Co Forward Dividend Yield % Related Terms
SZSE:000963 vs ZTS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huadong Medicine Co Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Huadong Medicine Co's Forward Dividend Yield % falls into.
Huadong Medicine Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Huadong Medicine Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.580000
2026-06-10
2026-06-09
2026-06-10
Cash Dividend
semi-annually
CNY:CNY 1.000000
CNY 0.350000
2025-09-18
2025-09-17
2025-09-18
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Huadong Medicine Co's Forward Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 3.42% mean?
Huadong Medicine Co (SZSE:000963) has a Forward Dividend Yield % of 3.42% as of Aug. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Huadong Medicine Co and its competitors. According to the industry distribution chart, Huadong Medicine Co ranks #137 out of 505 companies in the Drug Manufacturers industry, placing it in the top 27.1%.
Is Huadong Medicine Co's Forward Dividend Yield % too high?
Huadong Medicine Co's current Forward Dividend Yield % is 3.42%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.03. Huadong Medicine Co's value of 3.42% is 68.5% above this industry median. Based on the distribution chart, Huadong Medicine Co ranks #137 out of 505 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Huadong Medicine Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Huadong Medicine Co's Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Huadong Medicine Co ranks #137 out of 505 companies for Forward Dividend Yield %. This puts Huadong Medicine Co in the upper half of its industry. The industry median Forward Dividend Yield % is 2.03. Huadong Medicine Co's value of 3.42% is 68.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.03, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huadong Medicine Co's current Forward Dividend Yield % of 3.42% is 68.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Huadong Medicine Co and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huadong Medicine Co's current Forward Dividend Yield % is 3.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huadong Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Huadong Medicine Co (SZSE:000963) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥39.90, compared to a current price of ¥27.31 — trading 31.6% below its estimated fair value. The current Forward Dividend Yield % is 3.42% and 68.5% above the Drug Manufacturers industry median of 2.03. Huadong Medicine Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Huadong Medicine Co (SZSE:000963), the current Forward Dividend Yield % is 3.42% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huadong Medicine Co (SZSE:000963) Overvalued in 2026?
Based on GuruFocus' analysis, Huadong Medicine Co stock appears to be undervalued.
The current stock price of ¥27.31 is trading 31.6% below its estimated GF Value™ of ¥39.90.
GuruFocus considers Huadong Medicine Co to be Significantly Undervalued.
Key valuation signals for SZSE:000963:
Forward Dividend Yield %: 3.42%
GF Value™: ¥39.90 vs. price of ¥27.31 (31.6% below fair value)
Industry Position: 68.5% above the Drug Manufacturers median (#137 of 505)
No single metric tells the full story. See the SZSE:000963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drug products. The company mainly operates its business through three segments. The Manufacturing Business segment is engaged in the research and development, production, and marketing of specialized medicines, medicines for chronic diseases, as well as special medicines. The Commercial Business segment is engaged in the sales of medicines, medical devices, ginseng, and antler pieces. The International Medical Beauty Business segment is engaged in the production and sales of regeneration products, hyaluronic acids, and botulinum toxin products.
88GF Score
Get the complete analysis for SZSE:000963
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000963 has been successfully added to your 
